Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Epilepsia|February 27, 2007
Pharmacokinetics and drug interactions with zonisamideGraeme Sills, Martin BrodieBMJ Open|August 28, 2020
Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II)Silviya Balabanova, Claire Taylor, Graeme Sills, et al.Lancet (London, England)|April 11, 2021
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trialAnthony Marson, Girvan Burnside, Richard Appleton, et al.Lancet (London, England)|April 11, 2021
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trialAnthony Marson, Girvan Burnside, Richard Appleton, et al.Health Technology Assessment (Winchester, England)|December 21, 2021
Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTsAnthony G Marson, Girvan Burnside, Richard Appleton, et al.Clinical Pharmacology and Therapeutics|May 9, 2019
Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity ReactionsPaola Nicoletti, Sarah Barrett, Laurence McEvoy, et al.Epileptic Disorders : International Epilepsy Journal with Videotape|May 26, 2007
Genetics of epilepsy: epilepsy research foundation workshop reportSanjay Sisodiya, J Helen Cross, Ingmar Blümcke, et al.Pageof 1